These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32982951)

  • 1. Clinical Characteristics and Outcome of Patients With Hemorrhagic Transformation After Intravenous Thrombolysis in the WAKE-UP Trial.
    Jensen M; Schlemm E; Cheng B; Lettow I; Quandt F; Boutitie F; Ebinger M; Endres M; Fiebach JB; Fiehler J; Galinovic I; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G
    Front Neurol; 2020; 11():957. PubMed ID: 32982951
    [No Abstract]   [Full Text] [Related]  

  • 2. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.
    Dzialowski I; Pexman JH; Barber PA; Demchuk AM; Buchan AM; Hill MD;
    Stroke; 2007 Jan; 38(1):75-9. PubMed ID: 17122437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial.
    Frey BM; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Ford I; Galinovic I; Königsberg A; Puig J; Roy P; Wouters A; Magnus T; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
    Neurol Res Pract; 2020; 2():40. PubMed ID: 33324940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion.
    Molina CA; Alvarez-Sabín J; Montaner J; Abilleira S; Arenillas JF; Coscojuela P; Romero F; Codina A
    Stroke; 2002 Jun; 33(6):1551-6. PubMed ID: 12052990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
    Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
    N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial.
    Frey BM; Shenas F; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Galinovic I; Barow E; Königsberg A; Schlemm E; Pedraza S; Lemmens R; Thijs V; Muir KW; Nighoghossian N; Simonsen CZ; Gerloff C; Thomalla G;
    Stroke; 2023 Jul; 54(7):1718-1725. PubMed ID: 37226772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added Prognostic Value of Hemorrhagic Transformation Quantification in Patients With Acute Ischemic Stroke.
    van Kranendonk KR; Treurniet KM; Boers AMM; Berkhemer OA; Coutinho JM; Lingsma HF; van Zwam WH; van der Lugt A; van Oostenbrugge RJ; Dippel DWJ; Roos YBWEM; Marquering HA; Majoie CBLM;
    Front Neurol; 2020; 11():582767. PubMed ID: 33240206
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial.
    Barow E; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Ford I; Galinovic I; Nickel A; Puig J; Roy P; Wouters A; Magnus T; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
    JAMA Neurol; 2019 Jun; 76(6):641-649. PubMed ID: 30907934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Smoking Does Not Modify the Treatment Effect of Intravenous Thrombolysis in Acute Ischemic Stroke Patients-A
    Schlemm L; Kufner A; Boutitie F; Nave AH; Gerloff C; Thomalla G; Simonsen CZ; Ford I; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Ebinger M; Endres M
    Front Neurol; 2019; 10():1239. PubMed ID: 31824412
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemorrhagic Transformations after Thrombectomy: Risk Factors and Clinical Relevance.
    Kaesmacher J; Kaesmacher M; Maegerlein C; Zimmer C; Gersing AS; Wunderlich S; Friedrich B; Boeckh-Behrens T; Kleine JF
    Cerebrovasc Dis; 2017; 43(5-6):294-304. PubMed ID: 28343220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early infarct FLAIR hyperintensity is associated with increased hemorrhagic transformation after thrombolysis.
    Kufner A; Galinovic I; Brunecker P; Cheng B; Thomalla G; Gerloff C; Campbell BC; Nolte CH; Endres M; Fiebach JB; Ebinger M
    Eur J Neurol; 2013 Feb; 20(2):281-5. PubMed ID: 22900825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Early Neurological Improvement and Its Relationship to Thrombolysis Treatment and Long-Term Outcome in the WAKE-UP Study.
    Heinze M; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Puig J; Lemmens R; Thijs V; Muir KW; Nighoghossian N; Königsberg A; Jensen M; Barow E; Lettow I; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G
    Cerebrovasc Dis; 2023; 52(5):560-566. PubMed ID: 36863328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of White Blood Cell Count With Clinical Outcome Independent of Treatment With Alteplase in Acute Ischemic Stroke.
    Barow E; Quandt F; Cheng B; Gelderblom M; Jensen M; Königsberg A; Boutitie F; Nighoghossian N; Ebinger M; Endres M; Fiebach JB; Thijs V; Lemmens R; Muir KW; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G
    Front Neurol; 2022; 13():877367. PubMed ID: 35769368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
    Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction factors and clinical significance of different types of hemorrhagic transformation after intravenous thrombolysis.
    Hao Y; Zhou H; Pan C; Xie G; Hu J; Zhang B; Qian S; Yan S;
    Eur J Med Res; 2023 Nov; 28(1):509. PubMed ID: 37951926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Discrepancy between Measured versus Stated Weight on Hemorrhagic Transformation and Clinical Outcomes after Intravenous Alteplase Thrombolysis.
    Shin DH; Kang MJ; Kim JW; Shin DJ; Park HM; Sung YH; Kim EY
    Cerebrovasc Dis; 2017; 44(5-6):241-247. PubMed ID: 28848080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort.
    Fiorelli M; Bastianello S; von Kummer R; del Zoppo GJ; Larrue V; Lesaffre E; Ringleb AP; Lorenzano S; Manelfe C; Bozzao L
    Stroke; 1999 Nov; 30(11):2280-4. PubMed ID: 10548658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Imaging Markers Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke.
    van Kranendonk KR; Treurniet KM; Boers AMM; Berkhemer OA; van den Berg LA; Chalos V; Lingsma HF; van Zwam WH; van der Lugt A; van Oostenbrugge RJ; Dippel DWJ; Roos YBWEM; Marquering HA; Majoie CBLM;
    Stroke; 2019 Aug; 50(8):2037-2043. PubMed ID: 33755497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Galinovic I; Boutitie F; Fiebach JB; Villringer K; Cheng B; Ebinger M; Endres M; Fiehler J; Ford I; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Roy P; Gerloff C; Thomalla G
    Front Neurol; 2019; 10():983. PubMed ID: 31572293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.